Other News

Congressman Bilirakis discusses FDASIA implementation at Rare Disease Caucus Briefing

09/13/2013 0 Comments Contact Our News Editors

News Topic: 

Congressman Gus Bilirakis (R-FL) spoke at the Rare Disease Congressional Caucus Briefing on September 12, 2013 about the bipartisan letter being circulated by Members of Congress calling on the FDA to develop a clear guidance on the evidentiary criteria for Accelerated Approval for rare diseases. The letter asks FDA to fully implement FDASIA to provide a clear, workable framework for rare disease drug development.

Rare Disease of Interest: 
All Diseases